Cargando…
Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS
BACKGROUND: Traditionally GS is used to treat diabetes mellitus. Drug-herb interaction of GS via cytochrome P450 enzyme system by substrate cocktail method using HLM has not been reported. OBJECTIVE: To evaluate the in-vitro modulatory effects of GS extracts (aqueous, methanol, ethyl acetate, chloro...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068113/ https://www.ncbi.nlm.nih.gov/pubmed/27761064 http://dx.doi.org/10.4103/0973-1296.191441 |
_version_ | 1782460756695973888 |
---|---|
author | Rammohan, Bera Samit, Karmakar Chinmoy, Das Arup, Saha Amit, Kundu Ratul, Sarkar Sanmoy, Karmakar Dipan, Adhikari Tuhinadri, Sen |
author_facet | Rammohan, Bera Samit, Karmakar Chinmoy, Das Arup, Saha Amit, Kundu Ratul, Sarkar Sanmoy, Karmakar Dipan, Adhikari Tuhinadri, Sen |
author_sort | Rammohan, Bera |
collection | PubMed |
description | BACKGROUND: Traditionally GS is used to treat diabetes mellitus. Drug-herb interaction of GS via cytochrome P450 enzyme system by substrate cocktail method using HLM has not been reported. OBJECTIVE: To evaluate the in-vitro modulatory effects of GS extracts (aqueous, methanol, ethyl acetate, chloroform and n-hexane) and deacylgymnemic acid (DGA) on human CYP1A2, 2C8, 2C9, 2D6 and 3A4 activities in HLM. MATERIAL AND METHODS: Probe substrate-based LCMS/MS method was established for all CYPs. The metabolite formations were examined after incubation of probe substrates with HLM in the presence or absence of extracts and DGA. The inhibitory effects of GS extracts and DGA were characterized with kinetic parameters IC50 and Ki values. RESULTS: GS extracts showed differential effect on CYP activities in the following order of inhibitory potency: ethyl acetate > Chloroform > methanol > n-hexane > aqueous > DGA. This differential effect was observed against CYP1A2, 2C9 and less on CYP3A4 and 2C8 but all CYPs were unaffected by aqueous extract and DGA. The ethyl acetate and chloroform extract exhibited moderate inhibition towards CYP1A2 and 3A4. The aqueous extract and DGA however showed negligible inhibition towards all five major human CYPs with very high IC50 values (>90μg/ml). CONCLUSION: The results of our study revealed that phytoconstituents contained in GS, particularly in ethyl acetate and chloroform extracts, were able to inhibit CYP1A2, 3A4 and 2C9. The presence of relatively small, lipophillic yet slightly polar compounds within the GS extracts may be attributed for inhibition activities. These suggest that the herb or its extracts should be examined for potential pharmacokinetic drug interactions in vivo. Abbreviations used: GS: Gymnema sylvestre, GSE: Gymnema sylvestre extract, DGA: deacyl gymnemic acid, CYP: cytochrome P450, DMSO: dimethylsulphoxide, HLM: human liver microsomes, LC-MS/MS: liquid chromatography tandem mass spectroscopy, NADPH: reduced nicotinamide adeninedinucleotide phosphate, NRS: nicotinamide adeninedinucleotide phosphate regenerating system, CHE: chloroform extract, EAE: ethyl acetate extract, NHE- n-hexane extract, AE: aqueous extract, ME: methanol extract |
format | Online Article Text |
id | pubmed-5068113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-50681132016-10-19 Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS Rammohan, Bera Samit, Karmakar Chinmoy, Das Arup, Saha Amit, Kundu Ratul, Sarkar Sanmoy, Karmakar Dipan, Adhikari Tuhinadri, Sen Pharmacogn Mag Original Article BACKGROUND: Traditionally GS is used to treat diabetes mellitus. Drug-herb interaction of GS via cytochrome P450 enzyme system by substrate cocktail method using HLM has not been reported. OBJECTIVE: To evaluate the in-vitro modulatory effects of GS extracts (aqueous, methanol, ethyl acetate, chloroform and n-hexane) and deacylgymnemic acid (DGA) on human CYP1A2, 2C8, 2C9, 2D6 and 3A4 activities in HLM. MATERIAL AND METHODS: Probe substrate-based LCMS/MS method was established for all CYPs. The metabolite formations were examined after incubation of probe substrates with HLM in the presence or absence of extracts and DGA. The inhibitory effects of GS extracts and DGA were characterized with kinetic parameters IC50 and Ki values. RESULTS: GS extracts showed differential effect on CYP activities in the following order of inhibitory potency: ethyl acetate > Chloroform > methanol > n-hexane > aqueous > DGA. This differential effect was observed against CYP1A2, 2C9 and less on CYP3A4 and 2C8 but all CYPs were unaffected by aqueous extract and DGA. The ethyl acetate and chloroform extract exhibited moderate inhibition towards CYP1A2 and 3A4. The aqueous extract and DGA however showed negligible inhibition towards all five major human CYPs with very high IC50 values (>90μg/ml). CONCLUSION: The results of our study revealed that phytoconstituents contained in GS, particularly in ethyl acetate and chloroform extracts, were able to inhibit CYP1A2, 3A4 and 2C9. The presence of relatively small, lipophillic yet slightly polar compounds within the GS extracts may be attributed for inhibition activities. These suggest that the herb or its extracts should be examined for potential pharmacokinetic drug interactions in vivo. Abbreviations used: GS: Gymnema sylvestre, GSE: Gymnema sylvestre extract, DGA: deacyl gymnemic acid, CYP: cytochrome P450, DMSO: dimethylsulphoxide, HLM: human liver microsomes, LC-MS/MS: liquid chromatography tandem mass spectroscopy, NADPH: reduced nicotinamide adeninedinucleotide phosphate, NRS: nicotinamide adeninedinucleotide phosphate regenerating system, CHE: chloroform extract, EAE: ethyl acetate extract, NHE- n-hexane extract, AE: aqueous extract, ME: methanol extract Medknow Publications & Media Pvt Ltd 2016-07 /pmc/articles/PMC5068113/ /pubmed/27761064 http://dx.doi.org/10.4103/0973-1296.191441 Text en Copyright: © Pharmacognosy Magazine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Rammohan, Bera Samit, Karmakar Chinmoy, Das Arup, Saha Amit, Kundu Ratul, Sarkar Sanmoy, Karmakar Dipan, Adhikari Tuhinadri, Sen Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS |
title | Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS |
title_full | Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS |
title_fullStr | Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS |
title_full_unstemmed | Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS |
title_short | Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MS |
title_sort | human cytochrome p450 enzyme modulation by gymnema sylvestre: a predictive safety evaluation by lc-ms/ms |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068113/ https://www.ncbi.nlm.nih.gov/pubmed/27761064 http://dx.doi.org/10.4103/0973-1296.191441 |
work_keys_str_mv | AT rammohanbera humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms AT samitkarmakar humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms AT chinmoydas humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms AT arupsaha humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms AT amitkundu humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms AT ratulsarkar humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms AT sanmoykarmakar humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms AT dipanadhikari humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms AT tuhinadrisen humancytochromep450enzymemodulationbygymnemasylvestreapredictivesafetyevaluationbylcmsms |